Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jason Pharmaceuticals is a wholly-owned subsidiary of Medifast, Inc., specializing in the development and manufacture of clinically proven weight management and health-related products. Founded by a physician in 1980, the company produces a wide range of meal replacement shakes, bars, and snacks designed for medical weight loss programs. Its products are primarily distributed through the OPTAVIA brand and are used in programs recommended by thousands of healthcare professionals. The company maintains a focus on portion-controlled, nutritionally balanced formulations to support metabolic health and long-term weight maintenance. Jason Pharmaceuticals operates as the primary manufacturing and research arm for its parent company's clinical nutrition portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jason Pharmaceuticals.